The BRACANALYSIS brand, founded in 1996 (United States), from 28 sister brands and 2617 competing brands. BRACANALYSIS is owned by Myriad Genetics, listed on the stock exchange of New York BRACANALYSIS is part of the Medical Diagnostics & Research activity sector.
Share price and profitability of the share Myriad Genetics (BRACANALYSIS)
Buy Myriad Genetics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Myriad Genetics
(BRACANALYSIS)
over 5 years*
USD 10.29
Stock market history Myriad Genetics (BRACANALYSIS)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
